Basic Information
Basic information for OLMALINC-214-41aa
Peptide Name OLMALINC-214-41aa
Genome Position chr10:100373654-100373776[+]
Species Human
Peptide Sequence MRTCHSVRPRTVLQNSESFPDGWRSRSLPAEVPSLPCWEDK
Peptide Length 41
Unique No (OLMALINC-201-41aa,OLMALINC-202-41aa,OLMALINC-203-41aa,OLMALINC-204-41aa,OLMALINC-205-41aa,OLMALINC-206-41aa,OLMALINC-207-41aa,OLMALINC-208-41aa,OLMALINC-209-41aa,OLMALINC-210-41aa,OLMALINC-211-41aa,OLMALINC-212-41aa,OLMALINC-213-41aa,OLMALINC-215-41aa,OLMALINC-216-41aa,OLMALINC-217-41aa,OLMALINC-218-41aa,OLMALINC-219-41aa,OLMALINC-220-41aa,OLMALINC-221-41aa,OLMALINC-222-41aa,OLMALINC-223-41aa,OLMALINC-226-41aa,OLMALINC-227-41aa,OLMALINC-228-41aa,OLMALINC-229-41aa,OLMALINC-230-41aa,OLMALINC-231-41aa,OLMALINC-232-41aa,OLMALINC-234-41aa,OLMALINC-236-41aa)
Grand Average of Hydropathicity -0.8537
Relative Molecular Mass 5477
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000235823;OLMALINC
Transcript ID/Name ENST00000659075;OLMALINC-214
Transcript Length 1618
Coding Ability 0.563
DNA Sequence Corresponding to Peptide ATGCGGACATGCCACTCAGTCCGGCCGCGAACAGTGCTCCAGAACTCAGAGAGTTTTCCAGACGGGTGGAGATCGCGTTCCCTGCCCGCCGAGGTCCCATCGCTTCCCTGCTGGGAAGACAAA
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :